Please Wait
Applying Filters...

Approved Marketing Authorisations (MA) containing Lixisenatidum in Europe. Original Data : EMA Website

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Sanofi-Aventis (Switzerland) SA

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
Left Arrow
Right Arrow

01

arrow
AAPS 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Switzerland

Insulinum glarginum; Lixisenatidum

Brand Name : Suliqua 100/33

Dosage Form : Inj Loose Solostar

Dosage Strength : 100/33

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

Sanofi Company Banner

02

arrow
AAPS 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info :

Registration Country : Switzerland

Insulinum glarginum; Lixisenatidum

Brand Name : Suliqua 100/50

Dosage Form : Inj L?s Solostar

Dosage Strength : 100/50

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

Sanofi Company Banner